These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17090360)

  • 1. Clinical inquiries. What is the risk of adverse outcomes in a woman who develops mild hypertension from OCs?
    Pollara T; Kelsberg G; Safranek S; Schrager S
    J Fam Pract; 2006 Nov; 55(11):986-8. PubMed ID: 17090360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical inquiries. What lifestyle changes should we recommend for the patient with newly diagnosed hypertension?
    McDonald KC; Blackwell JC; Meurer LN
    J Fam Pract; 2006 Nov; 55(11):991-3. PubMed ID: 17090361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives.
    Brown RD
    J Tenn Med Assoc; 1975 Sep; 68(9):720, 722. PubMed ID: 1186221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contraceptive patch in relation to ischemic stroke and acute myocardial infarction.
    Jick SS; Jick H
    Pharmacotherapy; 2007 Feb; 27(2):218-20. PubMed ID: 17253912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retinal damage and oral contraceptives].
    Swane Lund FN; Nielsen NV
    Ugeskr Laeger; 1976 Jan; 138(4):219-21. PubMed ID: 1251482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myocardial infarction and oral contraceptives].
    Bounhoure JP; Galinier M; Roncalli J; Assoun B; Puel J
    Bull Acad Natl Med; 2008 Mar; 192(3):569-79; discussion 579. PubMed ID: 18819701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraceptives, hypertension and nephrosclerosis (author's transl)].
    Girndt J; Kramer P; Quellhorst E; Held K; Bohle A; Scheler F
    Dtsch Med Wochenschr; 1976 Aug; 101(34):1246-51. PubMed ID: 947733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical inquiries. What are contraindications to IUDs?
    Paladine HL; Blenning CE; Judkins DZ; Mittal S
    J Fam Pract; 2006 Aug; 55(8):726-9. PubMed ID: 16882450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women.
    Margolis KL; Adami HO; Luo J; Ye W; Weiderpass E
    Fertil Steril; 2007 Aug; 88(2):310-6. PubMed ID: 17624338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA; Norman H; Doherty M; Walker AM
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast feeding, but not use of oral contraceptives, is associated with a reduced risk of rheumatoid arthritis.
    Pikwer M; Bergström U; Nilsson JA; Jacobsson L; Berglund G; Turesson C
    Ann Rheum Dis; 2009 Apr; 68(4):526-30. PubMed ID: 18477739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and survival in breast cancer patients aged 20 to 54 years.
    Trivers KF; Gammon MD; Abrahamson PE; Lund MJ; Flagg EW; Moorman PG; Kaufman JS; Cai J; Porter PL; Brinton LA; Eley JW; Coates RJ
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1822-7. PubMed ID: 17855700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Loughlin J; Seeger JD; Eng PM; Foegh M; Clifford CR; Cutone J; Walker AM
    Contraception; 2008 Nov; 78(5):377-83. PubMed ID: 18929734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of adverse cardiovascular outcomes associated with antecedent hypertension after myocardial infarction.
    Chen G; Hemmelgarn B; Alhaider S; Quan H; Campbell N; Rabi D
    Am J Cardiol; 2009 Jul; 104(1):141-7. PubMed ID: 19576336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome after exposure to oral contraceptives during the periconceptional period.
    Ahn HK; Choi JS; Han JY; Kim MH; Chung JH; Ryu HM; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
    Hum Exp Toxicol; 2008 Apr; 27(4):307-13. PubMed ID: 18684801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of oral contraceptives and increased risk of cervical cancer].
    Schmeink CE; Lenselink CH; Bekkers RL
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1717-8. PubMed ID: 18727601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.